Logo image of IVCA

INVESTCORP AI ACQUISITION CO (IVCA) Stock Fundamental Analysis

NASDAQ:IVCA - KYG492191013 - Common Stock

12 USD
-0.09 (-0.74%)
Last: 5/7/2025, 8:13:16 PM
11.5 USD
-0.5 (-4.17%)
After Hours: 5/7/2025, 8:13:16 PM
Fundamental Rating

1

Overall IVCA gets a fundamental rating of 1 out of 10. We evaluated IVCA against 0 industry peers in the Unkown industry. IVCA has a bad profitability rating. Also its financial health evaluation is rather negative. IVCA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

IVCA had positive earnings in the past year.
In the past year IVCA has reported a negative cash flow from operations.
IVCA Yearly Net Income VS EBIT VS OCF VS FCFIVCA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 2M -2M 4M 6M 8M

1.2 Ratios

Industry RankSector Rank
ROA 22.57%
ROE 31.64%
ROIC N/A
ROA(3y)3.56%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IVCA Yearly ROA, ROE, ROICIVCA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 2 4 6 8

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for IVCA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IVCA Yearly Profit, Operating, Gross MarginsIVCA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

2

2. Health

2.1 Basic Checks

IVCA has less shares outstanding than it did 1 year ago.
IVCA has a worse debt/assets ratio than last year.
IVCA Yearly Shares OutstandingIVCA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M
IVCA Yearly Total Debt VS Total AssetsIVCA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 10.65 indicates that IVCA is not in any danger for bankruptcy at the moment.
A Debt/Equity ratio of 0.17 indicates that IVCA is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 10.65
ROIC/WACCN/A
WACCN/A
IVCA Yearly LT Debt VS Equity VS FCFIVCA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M 250M

2.3 Liquidity

IVCA has a Current Ratio of 0.03. This is a bad value and indicates that IVCA is not financially healthy enough and could expect problems in meeting its short term obligations.
IVCA has a Quick Ratio of 0.03. This is a bad value and indicates that IVCA is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
IVCA Yearly Current Assets VS Current LiabilitesIVCA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 500K 1M 1.5M

More info and screens

0

3. Growth

3.1 Past

IVCA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.28%.
EPS 1Y (TTM)-26.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-139.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 50.00, which means the current valuation is very expensive for IVCA.
When comparing the Price/Earnings ratio of IVCA to the average of the S&P500 Index (27.24), we can say IVCA is valued expensively.
Industry RankSector Rank
PE 50
Fwd PE N/A
IVCA Price Earnings VS Forward Price EarningsIVCA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IVCA Per share dataIVCA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

IVCA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INVESTCORP AI ACQUISITION CO

NASDAQ:IVCA (5/7/2025, 8:13:16 PM)

After market: 11.5 -0.5 (-4.17%)

12

-0.09 (-0.74%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)04-16 2025-04-16
Earnings (Next)N/A N/A
Inst Owners119.36%
Inst Owner Change-96.57%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap95.28M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 50
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 7.74
P/tB 7.74
EV/EBITDA N/A
EPS(TTM)0.24
EY2%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0
BVpS1.55
TBVpS1.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 22.57%
ROE 31.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)3.56%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z 10.65
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-139.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y11.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y68.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y68.17%
OCF growth 3YN/A
OCF growth 5YN/A